TY - DATA T1 - PDR levels per antiretroviral drug. PY - 2016/10/13 AU - Santiago Avila-Ríos AU - Claudia García-Morales AU - Margarita Matías-Florentino AU - Daniela Tapia-Trejo AU - Bismarck F. Hernández-Álvarez AU - Sumaya E. Moreira-López AU - Carlos J. Quant-Durán AU - Guillermo Porras-Cortés AU - Gustavo Reyes-Terán UR - https://plos.figshare.com/articles/figure/PDR_levels_per_antiretroviral_drug_/4029663 DO - 10.1371/journal.pone.0164156.g003 L4 - https://ndownloader.figshare.com/files/6489015 KW - 41L KW - Protease inhibitor PDR KW - HIV pre-treatment drug resistance KW - first-line ART regimens KW - Stanford HIVdb tool KW - SDRM KW - HIV referral center KW - Roberto Calder ón Hospital KW - NNRTI PDR KW - 103N KW - baseline HIV genotyping KW - Largest Public Hospital KW - representative HIVDR surveillance studies KW - Nicaragua KW - NGS KW - CI KW - 2015. HIV pol sequences KW - surveillance drug resistance mutation KW - Results 283 individuals KW - HIV Drug Resistance N2 - PDR levels per drug were estimated using the Stanford HIVdb tool, from Sanger sequences, and classified according to the Stanford Score (SS) as high: SS≥60, intermediate: SS 30–59, or low: 15–29. ER -